How is consent handled for autism therapy in minors?
Consent for autism therapy in the UK follows the same legal framework used across children’s healthcare. According to NHS England, children under 16 can sometimes consent to themselves if they have enough understanding of “what is involved in their treatment” known as Gillick competence. If they are not competent, someone with parental responsibility provides consent.
For 16–17-year-olds, the Mental Capacity Act (MCA) applies, meaning they are presumed able to consent unless there is clear evidence they lack capacity. The Care Quality Commission (CQC guidance) advises that records should show how competence or capacity was assessed before therapy begins.
What NICE says about consent in autism support
NICE guidance for children (CG170) states that informed consent must be obtained and documented, following national consent rules and GMC guidance (gmc-uk.org). Clinicians are expected to provide information in a developmentally appropriate way, explain options clearly, and make space for the child or young person to share their views.
(NICE CG128 draft) diagnostic guidance emphasises tailored communication, written information in accessible formats, and enough time to agree with the next steps with children, young people, and parents.
Involving children through assent
Consent may come from a parent or a competent child, but guidance increasingly stresses the importance of assent, meaning the child’s willingness to take part. A assent methodology review shows assent procedures in child therapies vary widely, yet experts agree that children should be asked whether they want to participate, and that dissent should be respected wherever possible. Emerging models in behavioural support also recommend defining and monitoring assent and adjusting therapy if a child indicates discomfort or withdrawal as shown in assent-based ABA/PBS paper.
Safeguarding, restrictive practices and children’s rights
The Royal College of Paediatrics and Child Health (RCPCH guidance) advises that written consent should be gained “where possible” and that the child’s welfare is always the overriding concern. Safeguarding frameworks highlight that any action restricting movement even environmental limitations counts as restraint and must be risk-assessed and recorded as shown in restraint guidance example.
Government policy on learning-disability and autism services reinforces personalised care, shared decision-making and supporting children to understand and express their views wherever possible according to Building the Right Support.
Why evidence gaps matter
Several reviews report that autism intervention studies often fail to monitor harm. A 2023 BMJ Project AIM meta-analysis found that adverse effects were “inadequately monitored,” making it difficult for families to fully understand risks when consenting to therapy. This underlines why transparent communication about uncertainty is part of good consent practice.
Key takeaway
Consent for autism therapy in minors is grounded in UK child-consent law: Gillick competence for under-16s, the MCA for 16–17-year-olds, and always the child’s best interests. Families should expect clear information, accessible communication, documented consent, and opportunities for children to express assent or dissent. A rights-based, person-centred approach protects wellbeing and ensures therapy is truly collaborative.
